Luiza Laborne Kalil, MD, MS
Assistant ProfessorCards
About
Research
Publications
Featured Publications
Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors
Kalil L, Craiglow B, King B. Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors. JAMA Dermatology 2025, 161: 1285-1287. PMID: 41060634, PMCID: PMC12509074, DOI: 10.1001/jamadermatol.2025.3537.Peer-Reviewed Original ResearchOral minoxidil treatment of alopecia areata
Kalil L, Valido K, Peterson D, King B. Oral minoxidil treatment of alopecia areata. Journal Of The American Academy Of Dermatology 2025, 93: 1099-1101. PMID: 40484133, DOI: 10.1016/j.jaad.2025.05.1446.Peer-Reviewed Original ResearchInnovation in Alopecia Areata
Kalil L, King B. Innovation in Alopecia Areata. Dermatologic Clinics 2024, 43: 27-33. PMID: 39542562, DOI: 10.1016/j.det.2024.09.001.Peer-Reviewed Original Research
2025
Development of the AAcQLI: A New Instrument for Assessing Quality of Life in Children With Alopecia Areata
Gomes I, Morgan M, Kalil L, Roth P, Giraldi S, Carvalho V. Development of the AAcQLI: A New Instrument for Assessing Quality of Life in Children With Alopecia Areata. International Journal Of Dermatology 2025 PMID: 41315876, DOI: 10.1111/ijd.70173.Peer-Reviewed Original ResearchQuality of lifeDisease-specific instrumentChildren's Dermatology Life Quality IndexInternal consistencyExcellent content validityQuality of Life IndexDermatology Life Quality IndexTest-retestContent validityConstruct validityPsychosocial impactLife Quality IndexPsychometric propertiesStudy sampleConvergent validityMeasurement propertiesAlopecia areataDiverse populationsLife IndexSeverity of alopeciaExpert CommitteeQoLPilot sampleQuality IndexCronbach's a coefficient167 Single-cell RNA sequencing nominates LAG3 as a potential therapeutic target for alopecia areata
Sanchez E, Wang Y, Kalil L, Peterson D, Hwang E, Yu W, Micevic G, Park K, King B, Damsky W. 167 Single-cell RNA sequencing nominates LAG3 as a potential therapeutic target for alopecia areata. Journal Of Investigative Dermatology 2025, 145: e58. DOI: 10.1016/j.jid.2025.09.182.Peer-Reviewed Original ResearchDiscontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
Ogbutor C, Chen L, Kalil L, Kelley K, Craiglow B, King B, Senna M. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series. International Journal Of Women's Dermatology 2025, 11: e218. PMID: 40810112, PMCID: PMC12348381, DOI: 10.1097/jw9.0000000000000218.Peer-Reviewed Original ResearchCombination oral minoxidil and baricitinib treatment of alopecia areata
Valido K, Kalil L, Peterson D, King B. Combination oral minoxidil and baricitinib treatment of alopecia areata. Journal Of The American Academy Of Dermatology 2025, 93: 1071-1073. PMID: 40383278, DOI: 10.1016/j.jaad.2025.05.1393.Peer-Reviewed Original ResearchSystemic Therapies for Pediatric Alopecia Areata
Kalil L, Welch D, Heath C, Craiglow B. Systemic Therapies for Pediatric Alopecia Areata. Pediatric Dermatology 2025, 42: 36-42. PMID: 40044621, DOI: 10.1111/pde.15822.Peer-Reviewed Original ResearchConceptsAlopecia areataSystemic therapyPediatric alopecia areataAutoimmune hair loss disorderJanus kinase inhibitorsHair loss disorderComorbid atopyOral minoxidilLong-term useSystemic corticosteroidsTopical therapySystemic treatmentPediatric AACase reportAdjunctive treatmentMild diseaseKinase inhibitorsImmunomodulatory medicinesTherapyExtensive involvementAdverse effectsNarrative reviewAreataPatientsTreatmentEnhanced hair regrowth with five monthly sessions of minoxidil-dutasteride-copper peptides tattooing for androgenetic alopecia assessed by artificial intelligence and blinded evaluators
Kuceki G, Coppinger A, Ragi S, Johnson L, Goren A, Kalil L, Cirino P, Wambier C. Enhanced hair regrowth with five monthly sessions of minoxidil-dutasteride-copper peptides tattooing for androgenetic alopecia assessed by artificial intelligence and blinded evaluators. JAAD International 2025, 20: 38-40. PMID: 40225275, PMCID: PMC11992372, DOI: 10.1016/j.jdin.2025.01.012.Peer-Reviewed Original Research
2020
Melanoma Awareness Among Medical Students
Kalil L, Prado E, Resende R, Pimenta M, Wainstein A, Drummond-Lage A. Melanoma Awareness Among Medical Students. Journal Of Cancer Education 2020, 36: 677-681. PMID: 31902090, DOI: 10.1007/s13187-019-01685-1.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Luiza Laborne Kalil, MD, is a dermatologist with a focused expertise in hair and scalp disorders. She specializes in the diagnosis and management of alopecia and other hair conditions, as well as acne, melasma, and eczema. She also performs both cosmetic dermatologic procedures and skin surgeries, providing comprehensive and individualized patient care.
As an assistant professor at Yale School of Medicine, Dr. Laborne Kalil is involved in medical education and clinical research. She is dedicated to mentoring future leaders in dermatology, with a particular passion for hair loss disorders.
Dr. Laborne Kalil received her medical degree at Faculdade de Ciências Médicas de Minas Gerais in Brazil, and completed a dermatology residency at Santa Casa de Misericórdia de Belo Horizonte (Brazil), followed by a postdoctoral fellowship in dermatology at Yale School of Medicine.
Clinical Specialties
Dermatology
Get In Touch
Contacts
Email
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.